A novel targeted oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor and its implications for patients with non-small cell lung cancer (NSCLC): A phase I clinical trial

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		01232naa a2200337 4500
001		oai:prod.swepub.kib.ki.se:126651174
003		SwePub
008		240811s2012 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1266511742 URI
040		a (SwePub)ki
041		a eng
042		9 SwePub
072	7	a vet2 swepub-contenttype
072	7	a kon2 swepub-publicationtype
100	1	a Ekman, S4 aut
245	1 0	a A novel targeted oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor and its implications for patients with non-small cell lung cancer (NSCLC): A phase I clinical trial
264	1	c 2012
700	1	a Harmenberg, J4 aut
700	1	a Frodin, JEu Karolinska Institutet4 aut
700	1	a Bergstrom, S4 aut
700	1	a Wassberg, C4 aut
700	1	a Eksborg, Su Karolinska Institutet4 aut
700	1	a Larsson, O4 aut
700	1	a Axelson, M4 aut
700	1	a Hedlund, A4 aut
700	1	a Alvfors, C4 aut
700	1	a Stahl, B4 aut
700	1	a Bergqvist, M4 aut
710	2	a Karolinska Institutet4 org
773	0	t JOURNAL OF CLINICAL ONCOLOGYg 30:15q 30:15x 0732-183X
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:126651174

By the author/editor: Ekman, S; Harmenberg, J; Frodin, JE; Bergstrom, S; Wassberg, C; Eksborg, S; show more...; Larsson, O; Axelson, M; Hedlund, A; Alvfors, C; Stahl, B; Bergqvist, M; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.